Showing results (1321-1330 of 1,337) with videos related to
Sort By:
Pageof 134
Cancer Medicine|May 18, 2023
A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort studyZheng Wu, Fengwei Tan, Yaozeng Xie, et al.BMC Medicine|March 3, 2026
Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trialZhiming Chen, Wenshuai Li, Yumeng Guo, et al.Thoracic Cancer|February 10, 2019
Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter studyDong-Hui Hou, Shi-Jun Zhao, Ju-Fang Shi, et al.JCO Clinical Cancer Informatics|February 7, 2020
The International Association for the Study of Lung Cancer Early Lung Imaging ConfederationJames L Mulshine, Ricardo S Avila, Ed Conley, et al.The Lancet. Respiratory Medicine|March 11, 2022
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort studyNi Li, Fengwei Tan, Wanqing Chen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2020
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLCShugeng Gao, Ning Li, Shunyu Gao, et al.The Lancet. Respiratory Medicine|October 20, 2019
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trialYunpeng Yang, Jianya Zhou, Jianying Zhou, et al.Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: Overall design and results from a multicenter retrospective epidemiologic surveyJu-Fang Shi, Le Wang, Ning Wu, et al.Nature Immunology|August 20, 2021
Selenium-GPX4 axis protects follicular helper T cells from ferroptosisYin Yao, Zhian Chen, Hao Zhang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA SequencingYunpeng Yang, Jie Huang, Tao Wang, et al.Pageof 134